medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2020, Number 6

<< Back

Acta Ortop Mex 2020; 34 (6)

Joint hypermobility syndrome

Carbonell-Bobadilla N, Rodríguez-Álvarez A, Rojas-García G, Barragán-Garfias J, Orrantia-Vertiz M, Rodríguez-Romo R

Language: Spanish
References: 42
Page: 441-449
PDF size: 216.60 Kb.


ABSTRACT

Joint hypermobility syndrome is an inherited disorder with autosomal dominant pattern; is characterized by joint hyperlaxity and musculoskeletal pains. Thermal hypermobility refers to the increase in active or passive movements of joints based on their normal ranges. Joint hypermobility syndrome also has gastrointestinal symptoms, sleep disorders, fibromyalgia, psychological disorders, migraine headache, ophthalmic, autonomic, among others. To diagnose hypermobility syndrome, Brighton's criteria are generally accepted and published in 1998. This criteria also known as benign joint hypermobility syndrome. The term benign is used to distinguish it from other more severe conditions such as Ehler-Danlos (classic or vascular type), Marfan syndrome, and imperfect osteogenesis. Treatment with physiotherapy and pharmacological means help improve patients' quality of life.


REFERENCES

  1. Fikree A, Aziz Q, Grahame R. Joint hypermobility syndrome. Rheum Dis Clin North Am. 2013; 39(2): 419-30.

  2. Hakim AJ, Grahame R. A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract. 2003; 57(3): 163-6.

  3. Bravo JF, Wolff C. Clinical study of hereditary disorders of connective tissues in a Chilean population: joint hypermobility syndrome and vascular Ehlers-Danlos syndrome. Arthritis Rheum. 2006; 54(2): 515-23.

  4. Grahame R, Edwards JC, Pitcher D, Gabell A, Harvey W. A clinical and echocardiographic study of patients with the hypermobility syndrome. Ann Rheum Dis. 1981; 40(6): 541-6.

  5. Kirk JA, Ansell BM, Bywaters EG. The hypermobility syndrome. Musculoskeletal complaints associated with generalized joint hypermobility. Ann Rheum Dis. 1967; 26(5): 419-25.

  6. Gazit Y, Menahem NA, Grahame R, Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med. 2003; 115(1): 33-40.

  7. Sacheti A, Szemere J, Bernstein B, Tafas T, Schechter N, Tsipouras P. Chronic pain is a manifestation of the Ehlers-Danlos syndrome. J Pain Symptom Manage. 1997; 14(2): 88-93.

  8. Zarate N, Farmer AD, Grahame R, Mohammed SD, Knowles CH, Scott SM, et al. Unexplained gastrointestinal symptoms and joint hypermobility: is connective tissue the missing link? Neurogastroenterol Motil. 2010; 22(3): 252-e78.

  9. Toker S, Soyucen E, Gulcan E, Kabay S, Ozbek O, Ozveren O, et al. Presentation of two cases with hypermobility syndrome and review of the related literatura. Eur J Phys Rehabil Med. 2010; 46(1): 89-94.

  10. Castori M, Morlino S, Celletti C, Celli M, Morrone A, Colombi M, et al. Management of pain and fatigue in the joint hypermobility syndrome (a.k.a. Ehlers-Danlos syndrome, hypermobility type): principles and proposal for a multidisciplinary approach. Am J Med Genet A. 2012; 158A: 2055-70.

  11. Sinibaldi L, Ursini G, Castori M. Psychopathological manifestations of joint hypermobility and joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type: the link between connective tissue and psychological distress revised. Am J Med Genet C Semin Med Gene. 2015; 169C: 97-106.

  12. Grahame R, Bravo J, Hasson N, Keer RJ. What is the joint hypermobility syndrome? JHS from the cradle to the grave, Chapter 2. Elsevier. 2010, 19-33.

  13. Pacey V, Tofts L, Wesley A, Collins F, Singh-Grewal D. Joint hypermobility syndrome: a review for clinicians. Review article. J Paediatr Child Health. 2015; 51(4): 373-80.

  14. Cattalini M, Khubchandani R, Cimaz R. When flexibility is not necessarily a virtue: review of hypermobility syndromes and chronic or recurrent musculoskeletal pain in children. Pediatr Rheumatol. 2015; 13(40): 1-9.

  15. Chang TH, Yuh DY, Wu YT, Cheng WC, Lin FG, Shieh YS, et al. The association between temporomandibular disorders and joint hypermobility syndrome: a nationwide population-based study. Clin Oral Investig. 2015; 19(8): 2123-32.

  16. Russek LN, Errico DM. Prevalence, injury rate and, symptom frequency in generalized joint laxity and joint hypermobility síndrome in a "healthy" college population. Clin Rheumatol. 2016; 35: 1029-39. doi: 10.1007/s10067-015-2951-9.

  17. Adib N, Davies K, Grahame R, Woo P, Murray KJ. Joint hypermobility syndrome in childhood. A not so benign multisystem disorder? Rheumatology. 2005; 44: 744-50.

  18. Flowers PP, Cleveland RJ, Schwartz TA, Nelson AE, Kraus VB, Hillstrom HJ, et al. Association between general joint hypermobility and knee, hip, and lumbar spine osteoarthritis by race: a cross-sectional study. Arthritis Research & Therapy. 2018; 1-7.

  19. Kovacic K, Chelimsky TC, Sood MR, Simpson P, Nugent M, Chelimsky G. Joint hypermobility: a common association with complex functional gastrointestinal disorders. J Pediatr. 2014; 165(5): 973-8.

  20. Smith TO, Easton V, Bacon H, Jerman E, Armon K, Poland F, et al. The relationship between benign joint hypermobility syndrome and psychological distress: a systematic review and meta-analysis. Rheumatology. 2014; 53(1): 114-22.

  21. Gharbiya M, Moramarco A, Castori M, Parisi F, Celletti C, Marenco M, et al. Ocular features in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type: a clinical and in vivo confocal microscopy study. Am J Ophthalmol. 2012; 154(3): 593-600.

  22. Nielsen RH, Couppé C, Jensen JK, Olsen MR, Heinemeier KM, Malfait F. Low tendon stiffness and abnormal ultrastructure distinguish classic Ehlers-Danlos syndrome from benign joint hypermobility syndrome in patients. FASEB J. 2014; 28: 4668-76.

  23. Johannessen EC, Reiten HS, Lovaas H, Maeland S, Juul-Kristensen B. Shoulder function, pain and health related quality of life in adults with joint hypermobility syndrome Ehlers-Danlos syndrome-hypermobility type. Disabil Rehabil. 2016; 38(14): 1282-90.

  24. Chen HC, Shah SH, Li YJ, Stabler TV, Jordan JM, Kraus VB. Inverse association of general joint hypermobility with hand and knee osteoarthritis and serum cartilage oligomeric matrix protein levels. Arthritis Rheum. 2008; 58(12): 3854-64.

  25. Watanabe A, Satoh K, Maniwa T, Matsumoto KI. Proteomic analysis for the identification of serum diagnostic markers for joint hypermobility syndrome. International Journal of Molecular Medicine. 2015; 461-7.

  26. Eccles JA, Beacher FD, Gray MA, Jones CL, Minati L, Harrison NA, et al. Brain structure and joint hypermobility: relevance to the expression of psychiatric symptoms. Br J Psychiatry. 2012; 200(6): 508-9.

  27. Castori M, Sperduti I, Celletti C, Camerota F, Grammatico P. Symptom and joint mobility progression in the joint hypermobility syndrome (Ehlers-Danlos syndrome, hypermobility type). Clin Exp Rheumatol. 2011; 29(6): 998-1005.

  28. Albayrak I, Yilmaz H, Ekrem AH, Salli A, Karaca G. Is pain the only symptom in patients with benign joint hypermobility syndrome? Clin Rheumatol. 2015; 34(9): 1613-9.

  29. Baeza-Velasco C, Van den BT, Grossin D, Hamonet C. Dif?culty eating and signi?cant weight loss in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Eat Weight Disord. 2015; 21(2): 175-83.

  30. Ghibellini G, Brancati F, Castor MI. Neurodevelopmental attributes of joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type: update and perspectives. Am J MedGenet. 2015; 169C(1): 107-16.

  31. Tobias JH, Deere K, Palmer S, Clark EM, Clinch J. Joint hypermobility is a risk factor for musculoskeletal pain during adolescence. Arthritis Rheum. 2013; 65: 1107-5.

  32. Bendik EM, Tinkle BT, Al-Shuik E, Levin L, Martin A, Thaler R, et al. Joint hypermobility syndrome: a common clinical disorder associated with migraine in women. Cephalalgia. 2011; 31(5): 603-13.

  33. Laszkowska M, Roy A, Lebwohl B, Green PH, Sundelin HE, Ludvigsson JF. Nationwide population-based cohor study of celiac disease and risk of Eglers-Danlos syndrome and joint hypermobility syndrome. Dig Liver Dis. 2016; 48: 1030-4.

  34. Fikree A, Grahame R, Aktar R, Farmer AD, Hakim AJ, Morris JK, et al. A prospective evaluation of undiagnosed joint hypermobility syndrome in patients with gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2014; 12(10): 1680-7.

  35. Kozanoglu E, Benlidayi IC, Akilli RE, Tasal A. Is there any link between joint hypermobility and mitral valve prolapse in patients with fibromyalgia syndrome? Clin Rheumatol. 2016; 35(4): 1041-4.

  36. Remvig L, Flycht L, Christensen KB, Juul-Kristensen B. Lack of consensus on tests and criteria for generalized joint hypermobility, Ehlers-Danlos syndrome: hypermobile type and joint hypermobility syndrome. Am J Med Genet Part A. 2014; 164A: 591-6.

  37. Tinkle BT, Bird HA, Grahame R, Lavallee M, Levy HP, Sillence D. The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Genet. 2009; 149A(11): 2368-70.

  38. Castori M, Colombi M. Generalized joint hypermobility, joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet Part C Semin Med Genet. 2015; 169C(1): 1-5.

  39. Castori M, Dordoni C, Morlino S, Sperduti I, Ritelli M, Valiante M, et al. Spectrum of mucocutaneous manifestations in 277 patients with joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet C Semin Med Genet. 2015; 169C: 43-53.

  40. Johnsson P, Kohlin C, Rasmusson G, Bengtsson A, Sturfelt G, Nived O. Differences in body structure and function between patients with systemic lupus erythematosus and healthy individuals, with particular reference to joint hypermobility. Scand J Rheumatol. 2016; 46(1): 40-3.

  41. Farmer AD, Douthwaite H, Gardiner S, Aziz Q, Grahame R. A novel in vivo skin extensibility test for joint hypermobility. J Rheumatol. 2010; 37: 1513-8.

  42. Castori M, Morlino S, Celletti C, Ghibellini G, Bruschini M, Grammatico P, et al. Re-writing the natural history of pain and related symptoms in the joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet A. 2013; 161A: 2989-3004.




2020     |     www.medigraphic.com